The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Cholangiocarcinoma: Current Knowledge and New Developments
Open accessAbstract
Cholangiocarcinoma (CCA) is the second most common primary malignancy. Although it is more common in Asia, its incidence in Europe and North America has significantly increased in recent decades. The prognosis of CCA is dismal. Surgery is the only potentially curative treatment, but the majority of patients present with advanced stage disease, and recurrence after resection is common. Over the last two decades, our understanding of the molecular biology of this malignancy has increased tremendously, diagnostic techniques have evolved, and novel therapeutic approaches have been established. This review discusses the changing epidemiologic trends and provides an overview of newly identified etiologic risk factors for CCA. Furthermore, the molecular pathogenesis is discussed as well as the influence of etiology and biliary location on the mutational landscape of CCA. This review provides an overview of the diagnostic evaluation of CCA and its staging systems. Finally, new therapeutic options are critically reviewed, and future therapeutic strategies discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908721 · Cited by 4,406
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution
DeOliveira, M. L., Cunningham, S. C., Cameron, J. L., Kamangar, F., Winter, J. M., Lillemoe, K. D., Choti, M. A., Yeo, C. J., & Schulick, R. D. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251366.62632.d3 · Cited by 1,300
Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy
Wang, Y., Li, J., Xia, Y., Gong, R., Wang, K., Yan, Z., Wan, X., Liu, G., Wu, D., Shi, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.5984 · Cited by 1,057
Preoperative Biliary Drainage for Cancer of the Head of the Pancreas
van der Gaag, N. A., Rauws, E. A. J., van Eijck, C. H. J., Bruno, M. J., van der Harst, E., Kubben, F. J. G. M., Gerritsen, J. J. G. M., Greve, J. W., Gerhards, M. F., de Hingh, I. H. J. T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903230 · Cited by 1,049
Risk factors for cholangiocarcinoma
Tyson, G. L., & El-Serag, H. B. (2011) · Hepatology · doi:10.1002/hep.24351 · Cited by 956
Endo, I., Gonen, M., Yopp, A. C., Dalal, K. M., Zhou, Q., Klimstra, D., D'Angelica, M., DeMatteo, R. P., Fong, Y., Schwartz, L., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318176c4d3 · Cited by 865
de Jong, M. C., Nathan, H., Sotiropoulos, G. C., Paul, A., Alexandrescu, S., Marques, H., Pulitano, C., Barroso, E., Clary, B. M., Aldrighetti, L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6519 · Cited by 729
Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
Everhart, J. E., & Ruhl, C. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.038 · Cited by 710
Jiao, Y., Pawlik, T. M., Anders, R. A., Selaru, F. M., Streppel, M. M., Lucas, D. J., Niknafs, N., Guthrie, V. B., Maitra, A., Argani, P., et al. (2013) · Nature Genetics · doi:10.1038/ng.2813 · Cited by 684
Nagino, M., Ebata, T., Yokoyama, Y., Igami, T., Sugawara, G., Takahashi, Y., & Nimura, Y. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182708b57 · Cited by 656
Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study
Ortner, M. E. J., Caca, K., Berr, F., Liebetruth, J., Mansmann, U., Huster, D., Voderholzer, W., Schachschal, G., Mössner, J., & Lochs, H. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.015 · Cited by 608
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
Chan, S. M., Thomas, D., Corces-Zimmerman, M. R., Xavy, S., Rastogi, S., Hong, W.-J., Zhao, F., Medeiros, B. C., Tyvoll, D. A., & Majeti, R. (2015) · Nature Medicine · doi:10.1038/nm.3788 · Cited by 577
Sia, D., Hoshida, Y., Villanueva, A., Roayaie, S., Ferrer, J., Tabak, B., Peix, J., Sole, M., Tovar, V., Alsinet, C., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.001 · Cited by 575
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
Burak, K., Angulo, P., Pasha, T. M., Egan, K., Petz, J., & Lindor, K. D. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04067.x · Cited by 557
Andersen, J. B., Spee, B., Blechacz, B. R., Avital, I., Komuta, M., Barbour, A., Conner, E. A., Gillen, M. C., Roskams, T., Roberts, L. R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.005 · Cited by 552
Self-citationRisk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
Shaib, Y. H., El-Serag, H. B., Davila, J. A., Morgan, R., & McGlynn, K. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.048 · Cited by 546
Welzel, T. M., Graubard, B. I., Zeuzem, S., El-Serag, H. B., Davila, J. A., & McGlynn, K. A. (2011) · Hepatology · doi:10.1002/hep.24397 · Cited by 543
Chan-on, W., Nairismägi, M.-L., Ong, C. K., Lim, W. K., Dima, S., Pairojkul, C., Lim, K. H., McPherson, J. R., Cutcutache, I., Heng, H. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2806 · Cited by 497
Exome sequencing of liver fluke–associated cholangiocarcinoma
Ong, C. K., Subimerb, C., Pairojkul, C., Wongkham, S., Cutcutache, I., Yu, W., McPherson, J. R., Allen, G. E., Ng, C. C. Y., Wong, B. H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2273 · Cited by 486
Lee, J., Park, S. H., Chang, H.-M., Kim, J. S., Choi, H. J., Lee, M. A., Chang, J. S., Jeung, H. C., Kang, J. H., Lee, H. W., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70301-1 · Cited by 478
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
Saha, S. K., Parachoniak, C. A., Ghanta, K. S., Fitamant, J., Ross, K. N., Najem, M. S., Gurumurthy, S., Akbay, E. A., Sia, D., Cornella, H., et al. (2014) · Nature · doi:10.1038/nature13441 · Cited by 460
Patel, A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00744-3 · Cited by 425
Sewnath, M. E., Karsten, T. M., Prins, M. H., Rauws, E. J. A., Obertop, H., & Gouma, D. J. (2002) · Annals of Surgery · doi:10.1097/00000658-200207000-00005 · Cited by 419
Levy, C., Lymp, J., Angulo, P., Gores, G. J., Larusso, N., & Lindor, K. D. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2927-8 · Cited by 339
Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study
Chalasani, N., Baluyut, A., Ismail, A., Zaman, A., Sood, G., Ghalib, R., McCashland, T. M., Reddy, R. K., Zervos, X., Anbari, M. A., et al. (2000) · Hepatology · doi:10.1002/hep.510310103 · Cited by 336
New staging system and a registry for perihilar cholangiocarcinoma
DeOliveira, M. L., Schulick, R. D., Nimura, Y., Rosen, C., Gores, G., Neuhaus, P., & Clavien, P.-A. (2011) · Hepatology · doi:10.1002/hep.24227 · Cited by 318
Sia, D., Losic, B., Moeini, A., Cabellos, L., Hao, K., Revill, K., Bonal, D., Miltiadous, O., Zhang, Z., Hoshida, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms7087 · Cited by 311
Choi, S.-B., Kim, K.-S., Choi, J.-Y., Park, S.-W., Choi, J.-S., Lee, W.-J., & Chung, J.-B. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0631-1 · Cited by 304
Rimola, J., Forner, A., Reig, M., Vilana, R., de Lope, C. R., Ayuso, C., & Bruix, J. (2009) · Hepatology · doi:10.1002/hep.23071 · Cited by 298
Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
Khan, S. A., Emadossadaty, S., Ladep, N. G., Thomas, H. C., Elliott, P., Taylor-Robinson, S. D., & Toledano, M. B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.015 · Cited by 290
Paik, W. H., Park, Y. S., Hwang, J.-H., Lee, S. H., Yoon, C. J., Kang, S.-G., Lee, J. K., Ryu, J. K., Kim, Y.-T., & Yoon, Y. B. (2009) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2008.04.005 · Cited by 282
Kluge, R., Schmidt, F., Caca, K., Barthel, H., Hesse, S., Georgi, P., Seese, A., Huster, D., & Berr, F. (2001) · Hepatology · doi:10.1053/jhep.2001.23912 · Cited by 265
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience
Lee, S. G., Song, G. W., Hwang, S., Ha, T. Y., Moon, D. B., Jung, D. H., Kim, K. H., Ahn, C. S., Kim, M. H., Lee, S. K., et al. (2010) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-009-0204-5 · Cited by 259
Matsuo, K., Rocha, F. G., Ito, K., D'Angelica, M. I., Allen, P. J., Fong, Y., DeMatteo, R. P., Gonen, M., Endo, I., & Jarnagin, W. R. (2012) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2012.05.025 · Cited by 220
Kim, J. Y., Kim, M.-H., Lee, T. Y., Hwang, C. Y., Kim, J. S., Yun, S.-C., Lee, S. S., Seo, D. W., & Lee, S. K. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01710.x · Cited by 216
de Jong, M. C., Marques, H., Clary, B. M., Bauer, T. W., Marsh, J. W., Ribero, D., Majno, P., Hatzaras, I., Walters, D. M., Barbas, A. S., et al. (2012) · Cancer · doi:10.1002/cncr.27492 · Cited by 214
Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
Mertens, J. C., Fingas, C. D., Christensen, J. D., Smoot, R. L., Bronk, S. F., Werneburg, N. W., Gustafson, M. P., Dietz, A. B., Roberts, L. R., Sirica, A. E., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2130 · Cited by 212
The Role of Inflammation in Cholestasis: Clinical and Basic Aspects
Kosters, A., & Karpen, S. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1253227 · Cited by 208
Trikudanathan, G., Navaneethan, U., Njei, B., Vargo, J. J., & Parsi, M. A. (2014) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2013.09.015 · Cited by 203 · cited 1×
“The sensitivity of cytology of biliary brushings is only 20% to 43%, but can be increased up to 46% to 68% through additional analysis for chromosomal aneuploidy using fluorescent in situ hybridization (FISH).(48,49) Single-operator peroral cholangioscopy (SOP) allows direct visualization of biliary defects, and guide…”
BackgroundEbata, T., Yokoyama, Y., Igami, T., Sugawara, G., Takahashi, Y., Nimura, Y., & Nagino, M. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31826029ca · Cited by 203
Hong, J. C. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.116 · Cited by 196
Yoon, J., Higuchi, H., Werneburg, N. W., Kaufmann, S. H., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32410 · Cited by 193
Boehm, L. M., Jayakrishnan, T. T., Miura, J. T., Zacharias, A. J., Johnston, F. M., Turaga, K. K., & Gamblin, T. C. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23781 · Cited by 181
Murad, S. D., Kim, W. R., Therneau, T. M., Gores, G. J., Rosen, C. B. B., Martenson, J. A., Alberts, S. R., & Heimbach, J. K. (2012) · Hepatology · doi:10.1002/hep.25629 · Cited by 150
Navaneethan, U., Njei, B., Venkatesh, P. G. K., Vargo, J. J., & Parsi, M. A. (2014) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2013.11.001 · Cited by 146
Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions
Voss, J. S., Holtegaard, L. M., Kerr, S. E., Fritcher, E. G. B., Roberts, L. R., Gores, G. J., Zhang, J., Highsmith, W. E., Halling, K. C., & Kipp, B. R. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.11.006 · Cited by 143
Sinakos, E., Saenger, A. K., Keach, J., Kim, W. R., & Lindor, K. D. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.02.007 · Cited by 142
Bertuccio, P., Bosetti, C., Levi, F., Decarli, A., Negri, E., & Vecchia, C. L. (2013) · Annals of Oncology · doi:10.1093/annonc/mds652 · Cited by 135
Kalaitzakis, E., Webster, G. J. M., Oppong, K. W., Kallis, Y. N., Vlavianos, P., Huggett, M. T., Dawwas, M. F., Lekharaju, V., Hatfield, A. R., Westaby, D., et al. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283526fa1 · Cited by 121
Galassi, M., Iavarone, M. A., Rossi, S. M., Bota, S. I., Vavassori, S., de la Rosa, L. E. S., Leoni, S., Venerandi, L., Marinelli, S., Sangiovanni, A., et al. (2013) · Liver International · doi:10.1111/liv.12124 · Cited by 117
Aggressive Surgical Resection for Hilar Cholangiocarcinoma of the Left-Side Predominance
Shimizu, H., Kimura, F., Yoshidome, H., Ohtsuka, M., Kato, A., Yoshitomi, H., Furukawa, K., & Miyazaki, M. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181be0085 · Cited by 113
Masselli, G., Manfredi, R. M., Vecchioli, A., & Gualdi, G. (2008) · European Radiology · doi:10.1007/s00330-008-1004-z · Cited by 107
Secular Trends in the Incidence of Cholangiocarcinoma in the USA and the Impact of Misclassification
Tyson, G. L., Ilyas, J. A., Duan, Z., Green, L., Younes, M., El‐Serag, H. B., & Davila, J. A. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3276-2 · Cited by 101
Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany
von Hahn, T., Ciesek, S., Wegener, G., Plentz, R. R., Weismüller, T. J., Wedemeyer, H., Manns, M. P., Greten, T. F., & Malek, N. P. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.589472 · Cited by 100
A New Clinically Based Staging System for Perihilar Cholangiocarcinoma
Chaiteerakij, R., Harmsen, W. S., Romero‐Marrero, C., Aboelsoud, M. M., Ndzengue, A., Kaiya, J. K., Therneau, T. M., Sánchez, W., Gores, G. J., & Roberts, L. R. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.327 · Cited by 95
Raggi, C., Invernizzi, P., & Andersen, J. B. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.09.007 · Cited by 93
Manta, R., Frazzoni, M., Conigliaro, R. L., Macciò, L., Melotti, G. L., Dabizzi, E., Bertani, H., Manno, M., Castellani, D., Villanacci, V., et al. (2012) · Surgical Endoscopy · doi:10.1007/s00464-012-2628-2 · Cited by 86
Moon, C. M., Bang, S., Chung, J. B., Park, S. W., Song, S. Y., Yun, M., & Lee, J. D. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05173.x · Cited by 72
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
Borad, M. J., Gores, G. J., & Roberts, L. R. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000171 · Cited by 57
Annunziata, S., Caldarella, C., Pizzuto, D. A., Galiandro, F., Sadeghi, R., Giovanella, L., & Treglia, G. (2014) · BioMed Research International · doi:10.1155/2014/247693 · Cited by 49
Cited by
Abou-Alfa, G. K., Macarulla, T., Javle, M. M., Kelley, R. K., Lubner, S. J., Adeva, J., Cleary, J. M., Catenacci, D. V., Borad, M. J., Bridgewater, J., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30157-1 · Cited by 1,116
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Lee, T., Teng, T. Z. J., & Shelat, V. G. (2020) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v12.i12.468 · Cited by 293
Ponsioen, C. Y., Assis, D. N., Boberg, K. M., Bowlus, C. L., Deneau, M., Thorburn, D., Aabakken, L., Färkkilä, M., Petersen, B., Rupp, C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.046 · Cited by 95
Metadata
- Authors
- Blechacz, B.
- Venue
- Gut and Liver
- Published
- 2017-01-15
- Volume
- 11
- Issue
- 1
- Pages
- 13-26
- ISSN
- 1976-2283 (ISSN-L)
- 2005-1212
- OpenAlex
- W2560087117
- Cited by
- 485
- References
- 62
- FWCI
- 32.19
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.